Mohammad Navid Soltani Rad

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Oxide Nanoparticles

Breast Cancer Cells

Inferior Vena Cava

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Navid Soltani Rad, Somayeh Behrouz, Maedeh Charbaghi, Marzieh Behrouz, Elham Zarenezhad, Ali Ghanbariasad
Design, synthesis, anticancer and in silico assessment of 8-caffeinyl chalcone hybrid conjugates. RSC advances 14 (36) (2024)
Mohammad Navid Soltani Rad, Somayeh Behrouz, Parichehr Halaj Yazdi, Seyedeh-Sara Hashemi, Marzieh Behrouz
Design, synthesis, analgesic, antibacterial and docking studies of novel 8-piperazinylcaffeine carboxylate ionic liquids. RSC advances 14 (39) (2024)
Mohammad Navid Soltani Rad, Somayeh Behrouz, Maedeh Charbaghi, Marzieh Behrouz, Elham Zarenezhad, Ali Ghanbariasad
Design, synthesis, anticancer and in silico assessment of 8-caffeinyl chalcone hybrid conjugates. RSC advances 14 (36) (2024)
Narjes Kaviani, Somayeh Behrouz, Abbas Ali Jafari, Mohammad Navid Soltani Rad
Functionalization of Fe 3 O 4 @SiO 2 nanoparticles with Cu(i)-thiosemicarbazone complex as a robust and efficient heterogeneous nanocatalyst for N -arylation of N-heterocycles with aryl halides. RSC advances 13 (43) (2023)
Mohammad Navid Soltani Rad, Somayeh Behrouz, Saleh Aghajani, Marzieh Behrouz, Elham Zarenezhad, Ali Ghanbariasad
Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates. RSC advances 13 (5) (2023)
Mohammad Navid Soltani Rad, Somayeh Behrouz, Kiana Shahbazkhani, Marzieh Behrouz, Elham Zarenezhad, Ali Ghanbariasad
Design, synthesis, anticancer and in silico assessment of 8-piperazinyl caffeinyl-triazolylmethyl hybrid conjugates. RSC advances 13 (35) (2023)
Mohammad Navid Soltani Rad, Somayeh Behrouz, Saleh Aghajani, Marzieh Behrouz, Elham Zarenezhad, Ali Ghanbariasad
Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates. RSC advances 13 (5) (2023)